Evidence map›Paper›PMID 35344562›Full record

ArticlePloS one2022

End-to-end antigenic variant generation for H1N1 influenza HA protein using sequence to sequence models.

Mohamed Elsayed Abbas, Zhu Chengzhang, Ahmed Fathalla, Yalong Xiao

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed Elsayed AbbasSchool of Computer Science and Engineering, Central South University, Changsha, China.ORCID 0000-0001-8896-328X
Zhu ChengzhangSchool of Computer Science and Engineering, Central South University, Changsha, China.ORCID 0000-0001-8825-0992
Ahmed FathallaDepartment of Mathematics, Faculty of Science,Suez Canal University, Ismailia, Egypt.
Yalong XiaoSchool of Computer Science and Engineering, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing risk of new variants of the influenza A virus is the most significant to public health. The risk imposed from new variants may have been lethal, as witnessed in the year 2009. Even though the improvement in predicting antigenicity of influenza viruses has rapidly progressed, few studies employed deep learning methodologies. The most recent literature mostly relied on classification techniques, while a model that generates the HA protein of the antigenic variant is not developed. However, the antigenic pair of influenza virus A can be determined in a laboratory setup, the process needs a tremendous amount of time and labor. Antigenic shift and drift which are caused by changes in surface protein favored the influenza A virus in evading immunity. The high frequency of the minor changes in the surface protein poses a challenge to identifying the antigenic variant of an emerging virus. These changes slow down vaccine selection and the manufacturing process. In this vein, the proposed model could help save the time and efforts exerted to identify the antigenic pair of the influenza virus. The proposed model utilized an end-to-end learning methodology relying on deep sequence-to-sequence architecture to generate the antigenic variant of a given influenza A virus using surface protein. Employing the BLEU score to evaluate the generated HA protein of the antigenic variant of influenza virus A against the actual variant, the proposed model achieved a mean accuracy of 97.57%.

Indexed as

Hemagglutinin Glycoproteins, Influenza VirusInfluenza A Virus, H1N1 SubtypeAntigenic VariationAntigens, ViralHumansInfluenza, HumanMembrane ProteinsAntigens, ViralHemagglutinin Glycoproteins, Influenza VirusMembrane Proteins

Identifiers

PMID35344562
PMCPMC8959165

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.